Who Owns Imunon Stock?
NASDAQ: IMNNHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 5.68%
- Held by insiders
- 6.06%
- Institutional holders
- 25
- Institutions 5.7%
- Insiders 6.1%
- Public and other 88.3%
Who owns Imunon stock?
Institutional investors own about 5.7% of Imunon's shares, spread across 25 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 6.06% of IMNN.
The largest institutional holders are Armistice Capital, LLC (2.58%), Vanguard Capital Management LLC (0.84%) and Riverview Capital Advisers, LLC (0.61%). Together, the top 10 institutions control 5.6% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their IMNN positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of IMNN
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Armistice Capital, LLC | 144.77K | 2.58% | -58.4% |
| Vanguard Capital Management LLC | 46.97K | 0.84% | -2.3% |
| Riverview Capital Advisers, LLC | 34.36K | 0.61% | 0.0% |
| Geode Capital Management, LLC | 31.63K | 0.56% | -4.8% |
| Virtu Financial LLC | 17.46K | 0.31% | +100.0% |
| Vanguard Fiduciary Trust Co | 13.27K | 0.24% | 0.0% |
| Northern Trust Corporation | 10.34K | 0.18% | +100.0% |
| UBS Group AG | 5.20K | 0.09% | +804.9% |
| Blackrock Inc. | 4.46K | 0.08% | 0.0% |
| Tower Research Capital LLC (TRC) | 3.95K | 0.07% | +111.8% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of IMNN
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 46.97K | 0.84% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 18.99K | 0.34% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 4.74K | 0.08% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 1.78K | 0.03% |
Frequently asked questions
Who is the largest shareholder of Imunon?
Armistice Capital, LLC is the largest institutional shareholder of IMNN, owning 2.58% of shares outstanding (144.77K shares) as of its latest 13F filing.
What percentage of Imunon is owned by institutions?
Institutions own about 5.7% of IMNN shares and 6.0% of the public float.
How much of Imunon do insiders own?
Insiders, such as officers and directors, own about 6.06% of IMNN shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.